{"prediction": {"id": "fd7d011a-4bd2-5a78-92b2-06f9cdaa1776", "work_id": "5714d41f-bedc-511e-9b2c-8a342e09c664", "study_id": "76c1e1e8-7914-56b7-afa5-df263cc0f539", "kind": "Model scenario comparison", "pages": [10], "version": "Version of record", "source_work_id": "5714d41f-bedc-511e-9b2c-8a342e09c664", "title": "Osimertinib Optimal Dosing Through Population Pharmacokinetics in Virtual Patients with NSCLC: An Approach Integrating Multiple Studies.", "doi": "10.3390/pharmaceutics18101332", "pdf_sha256": "53cc633b5136d3a11718f6f759527824b58ba1c6ef4c72d198ce55a1643f257a", "physical_page_count": 15}, "fields": {"endpoint": {"value": "steady_state_trough_drug_concentration__fraction_within_published_reference_interval", "source_basis": "verified_profile", "pages": [10]}, "family": {"value": "pharmacokinetic_exposure", "source_basis": "verified_profile", "pages": [10]}, "measured_variable": {"value": "steady_state_trough_drug_concentration", "source_basis": "verified_profile", "pages": [10]}, "measurement_role": {"value": "exposure_outcome", "source_basis": "original_pdf_review", "pages": [10]}, "metric": {"value": "fraction_within_published_reference_interval", "source_basis": "verified_profile", "pages": [10]}, "model": {"value": "mechanistic_or_numerical", "source_basis": "verified_profile", "pages": [1, 10, 13]}, "reference_type": {"value": "published_threshold_reference", "source_basis": "verified_profile", "pages": [10]}, "role": {"value": "simulated_output", "source_basis": "verified_profile", "pages": [10]}, "scenario": {"value": "within_model_scenario_comparison", "source_basis": "verified_profile", "pages": [10]}}, "endpoints": [{"term": "cohort_coverage", "label": "Cohort size and coverage"}, {"term": "pharmacokinetics", "label": "Pharmacokinetics and drug exposure"}], "validations": [{"id": "1f6d09f3-9db3-563b-b358-4a07a6f3aef5", "claim_id": "fd7d011a-4bd2-5a78-92b2-06f9cdaa1776", "coverage": "related_context", "support": "partial_support", "source": "unknown", "overlap": "unknown", "comparability": "partial", "statistics": "not_applicable", "anchors": [{"work_id": "5714d41f-bedc-511e-9b2c-8a342e09c664", "version": "Version of record", "pages": [13]}]}], "model_resources": {"total": 1, "page": 1, "limit": 50, "rows": [{"id": 545, "work_id": "5714d41f-bedc-511e-9b2c-8a342e09c664", "claim_id": "fd7d011a-4bd2-5a78-92b2-06f9cdaa1776", "kind": "model", "label": "Osimertinib integrated population pharmacokinetic model", "repository": "Author GitHub", "identifier": "IM-JW/Osimertinib_integrated_PK", "source_page": 14, "availability": "author_reported_public", "url": "https://github.com/IM-JW/Osimertinib_integrated_PK", "scope": "claim_specific", "resource_version": null, "version_basis": null, "repository_commit": null, "repository_member": null, "source_file_sha256": null, "source_basis": "legacy_curated_resource", "priority": 2, "doi": "10.3390/pharmaceutics18101332", "title": "Osimertinib Optimal Dosing Through Population Pharmacokinetics in Virtual Patients with NSCLC: An Approach Integrating Multiple Studies.", "version": "Version of record", "pdf_sha256": "53cc633b5136d3a11718f6f759527824b58ba1c6ef4c72d198ce55a1643f257a", "association_scope": "prediction", "resource_relation": "indexed_resource", "source_review": {"indexed": true, "source_basis": "legacy_curated_resource"}}], "review_status": "indexed_source"}}